Nitroquick (Glyceryl Trinitrate)

Glyceryl trinitrate, the active ingredient in Nitroquick, is a nitrate vasodilator presented as an oromucosal formulation for oromucosal use. It provides rapid relief of acute angina pectoris and is used to prevent angina attacks in patients with coronary artery disease, and it is available in the European Union market for physician‑prescribed cardiovascular therapy.

GNH USA supplies Nitroquick as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory‑compliant shipments to healthcare providers across multiple regions.

Nitroquick, a nitrate vasodilator, is employed in the management of angina‑related conditions.

Acute angina pectoris: rapid relief of chest pain by reducing myocardial oxygen demand. Prophylaxis of angina attacks: prevents recurrence of ischemic episodes in stable coronary disease. Chronic stable angina: improves exercise tolerance and reduces frequency of anginal episodes.

Nitroquick may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Headache: throbbing pain often occurring shortly after administration. - Flushing: warm sensation and redness of the skin. - Dizziness: light‑headed feeling, especially when standing quickly.

Serious or Rare Side Effects: - Severe hypotension: marked drop in blood pressure that may require medical attention. - Syncope: sudden loss of consciousness due to inadequate cerebral perfusion. - Methemoglobinemia: rare disorder reducing oxygen delivery in the blood.

When using Nitroquick, consider the following precautions: - Hypersensitivity: avoid in patients with known allergy to nitrates. - Severe hypotension: use with caution and monitor blood pressure closely. - Concomitant PDE‑5 inhibitors: contraindicated due to risk of profound hypotension. - Blood pressure monitoring: regular checks are recommended during therapy. - Store below 25°C: keep in the original container, protect from moisture and light.

Nitroquick can interact with several medicines; awareness of these interactions helps maintain safety.

Major Interactions (Avoid): - Sildenafil, tadalafil, vardenafil (PDE‑5 inhibitors): may cause severe hypotension. - Other nitrates (e.g., isosorbide dinitrate): additive vasodilatory effect. - Potent antihypertensive agents: increased risk of low blood pressure.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may mask tachycardia response. - Diuretics: can enhance blood‑pressure‑lowering effect. - Other antihypertensives: dose adjustments may be needed.